Amphetamines, new psychoactive drugs and the monoamine transporter cycle

Trends in Pharmacological Sciences

Volumn 36, Issue 1, 2015, Pages 41-50

  Sitte, Harald H ^a   Freissmuth, Michael ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

addiction; amphetamine; monoamine transporter; psychostimulant; regulation; reverse transport

Indexed keywords

4' METHYLMETHCATHINONE; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; AMPHETAMINE DERIVATIVE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CATHINONE; DEXAMPHETAMINE; DOPAMINE TRANSPORTER; EPHEDRINE; METHAMPHETAMINE; METHYLPHENIDATE; PHENETHYLAMINE; PROTEIN KINASE C; PYROVALERONE; SEROTONIN TRANSPORTER; VESICULAR MONOAMINE TRANSPORTER; VESICULAR MONOAMINE TRANSPORTER 1; VESICULAR MONOAMINE TRANSPORTER 2; PLASMA MEMBRANE NEUROTRANSMITTER TRANSPORTER; PSYCHOTROPIC AGENT;

AMINO TERMINAL SEQUENCE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CATHA; CONFORMATIONAL TRANSITION; DRUG IDENTIFICATION; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG TARGETING; EPHEDRA; HUMAN; INTRACELLULAR SIGNALING; MEMBRANE POTENTIAL; NONHUMAN; PALMITOYLATION; PROTEIN CONFORMATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; REVIEW; ANIMAL; CHEMISTRY; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL;

AMPHETAMINES; ANIMALS; BIOLOGICAL TRANSPORT; HUMANS; PLASMA MEMBRANE NEUROTRANSMITTER TRANSPORT PROTEINS; PSYCHOTROPIC DRUGS;

EID: 84920154818     PISSN: 01656147     EISSN: 18733735     Source Type: Journal    
DOI: 10.1016/j.tips.2014.11.006     Document Type: Review

References (100)

1. D. Sulzer Mechanisms of neurotransmitter release by amphetamines: a review Prog. Neurobiol. 75 2005 406 433
2. G. Barger, and H.H. Dale Chemical structure and sympathomimetic action of amines J. Physiol. 41 1910 19 59
3. J.H. Biel, and B.A. Bopp Amphetamines: structure-activity relationships L.L. Iversen, Handbook of Psychopharmacology: Stimulants 1978 Plenum 1 40
4. C.D. Rosenbaum Here today, gone tomorrow. and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines J. Med. Toxicol. 8 2012 15 32
5. E.A. Ross 'Bath salts' intoxication N. Engl. J. Med. 365 2011 967 968
6. S.D. Robertson A closer look at amphetamine-induced reverse transport and trafficking of the dopamine and norepinephrine transporters Mol. Neurobiol. 39 2009 73 80
7. L.A. Egana Physical and functional interaction between the dopamine transporter and the synaptic vesicle protein synaptogyrin-3 J. Neurosci. 29 2009 4592 4604
8. D. Peter The chromaffin granule and synaptic vesicle amine transporters differ in substrate recognition and sensitivity to inhibitors J. Biol. Chem. 269 1994 7231 7237
9. K. Erreger Currents in response to rapid concentration jumps of amphetamine uncover novel aspects of human dopamine transporter function J. Neurosci. 28 2008 976 989
10. S. Sucic The N terminus of monoamine transporters is a lever required for the action of amphetamines J. Biol. Chem. 285 2010 10924 10938
11. L.S. Seiden Amphetamine: effects on catecholamine systems and behavior Annu. Rev. Pharmacol. Toxicol. 33 1993 639 677
12. D. Sulzer Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport J. Neurosci. 15 1995 4102 4108
13. D. Sulzer Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons J. Neurochem. 60 1993 527 535
14. P. Scholze Transporter-mediated release: a superfusion study on human embryonic kidney cells stably expressing the human serotonin transporter J. Pharmacol. Exp. Ther. 293 2000 870 878
15. B.D. Safratowich Amphetamine activates an amine-gated chloride channel to generate behavioral effects in Caenorhabditis elegans J. Biol. Chem. 288 2013 21630 21637
16. S.M. Underhill Amphetamine modulates excitatory neurotransmission through endocytosis of the glutamate transporter EAAT3 in dopamine neurons Neuron 83 2014 404 416
17. S.R. Jones Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter J. Neurosci. 18 1998 1979 1986
18. B. Di Cara Genetic deletion of trace amine 1 receptors reveals their role in auto-inhibiting the actions of ecstasy (MDMA) J. Neurosci. 31 2011 16928 16940
19. F.G. Revel Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics Biol. Psychiatry 72 2012 934 942
20. B.D. Safratowich Amphetamine potentiates the effects of beta-phenylethylamine through activation of an amine-gated chloride channel J. Neurosci. 34 2014 4686 4691
21. A.S. Kristensen SLC6 neurotransmitter transporters: structure, function, and regulation Pharmacol. Rev. 63 2011 585 640
22. G. Rudnick Bioenergetics of neurotransmitter transport J. Bioenerg. Biomembr. 30 1998 173 185
23. J.L. Berfield Which form of dopamine is the substrate for the human dopamine transporter: the cationic or the uncharged species? J. Biol. Chem. 274 1999 4876 4882
24. O. Jardetzky Simple allosteric model for membrane pumps Nature 211 1966 969 970
25. A. Penmatsa, and E. Gouaux How LeuT shapes our understanding of the mechanisms of sodium-coupled neurotransmitter transporters J. Physiol. 592 2014 863 869
26. W. Sandtner A quantitative model of amphetamine action on the 5-HT transporter Br. J. Pharmacol. 171 2014 1007 1018
27. K. Schicker Unifying concept of serotonin transporter-associated currents J. Biol. Chem. 287 2012 438 445
28. + coupling Nat. Commun. 5 2014 4231
29. C. Perez Alternating-access mechanism in conformationally asymmetric trimers of the betaine transporter BetP Nature 490 2012 126 130
30. L.R. Forrest The structural basis of secondary active transport mechanisms Biochim. Biophys. Acta 1807 2011 167 188
31. H.H. Sitte Carrier-mediated release, transport rates, and charge transfer induced by amphetamine, tyramine, and dopamine in mammalian cells transfected with the human dopamine transporter J. Neurochem. 71 1998 1289 1297
32. M.S. Sonders Multiple ionic conductances of the human dopamine transporter: the actions of dopamine and psychostimulants J. Neurosci. 17 1997 960 974
33. S.V. Adams, and L.J. DeFelice Flux coupling in the human serotonin transporter Biophys. J. 83 2002 3268 3282
34. A. Su A multi-substrate single-file model for ion-coupled transporters Biophys. J. 70 1996 762 777
35. C.I. Petersen, and L.J. DeFelice Ionic interactions in the Drosophila serotonin transporter identify it as a serotonin channel Nat. Neurosci. 2 1999 605 610
36. S.R. Jones Dopamine neuronal transport kinetics and effects of amphetamine J. Neurochem. 73 1999 2406 2414
37. Y. Schmitz Amphetamine distorts stimulation-dependent dopamine overflow: effects on D2 autoreceptors, transporters, and synaptic vesicle stores J. Neurosci. 21 2001 5916 5924
38. H.H. Sitte Characterization of carrier-mediated efflux in human embryonic kidney 293 cells stably expressing the rat serotonin transporter: a superfusion study J. Neurochem. 74 2000 1317 1324
39. C. Pifl Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter Mol. Pharmacol. 47 1995 368 373
40. P. Scholze The role of zinc ions in reverse transport mediated by monoamine transporters J. Biol. Chem. 277 2002 21505 21513
41. +-dependent mechanism J. Biol. Chem. 278 2003 12070 12077
42. J.F. Fischer, and A.K. Cho Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model J. Pharmacol. Exp. Ther. 208 1979 203 209
43. J.A. Schmid Oligomerization of the human serotonin transporter and of the rat GABA transporter 1 visualized by fluorescence resonance energy transfer microscopy in living cells J. Biol. Chem. 276 2001 3805 3810
44. H.H. Sitte Sodium-dependent neurotransmitter transporters: oligomerization as a determinant of transporter function and trafficking Mol. Interv. 4 2004 38 47
45. A. Anderluh Tracking single serotonin transporter molecules at the endoplasmic reticulum and plasma membrane Biophys. J. 106 2014 L33 L35
46. A. Anderluh Single molecule analysis reveals coexistence of stable serotonin transporter monomers and oligomers in the live cell plasma membrane J. Biol. Chem. 289 2014 4387 4394
47. K.M. Kahlig Amphetamine induces dopamine efflux through a dopamine transporter channel Proc. Natl. Acad. Sci. U.S.A. 102 2005 3495 3500
48. A.A. Rodriguez-Menchaca S(+)amphetamine induces a persistent leak in the human dopamine transporter: molecular stent hypothesis Br. J. Pharmacol. 165 2012 2749 2757
49. D. Schmid The conservative view: is it necessary to implant a stent into the dopamine transporter? Br. J. Pharmacol. 2014 10.1111/bph.12766 Published online May 13
50. S. Seidel Amphetamines take two to tango: an oligomer-based counter-transport model of neurotransmitter transport explores the amphetamine action Mol. Pharmacol. 67 2005 140 151
51. --coupled neurotransmitter transporters - why amphetamines take two to tango J. Neurochem. 112 2010 340 355
52. N. Chen, and M.E. Reith Substrates dissociate dopamine transporter oligomers J. Neurochem. 105 2008 910 920
53. Y. Li Interrelation of dopamine transporter oligomerization and surface presence as studied with mutant transporter proteins and amphetamine J. Neurochem. 114 2010 873 885
54. W.C. Hong, and S.G. Amara Membrane cholesterol modulates the outward facing conformation of the dopamine transporter and alters cocaine binding J. Biol. Chem. 285 2010 32616 32626
55. S.M. Scanlon Membrane cholesterol modulates serotonin transporter activity Biochemistry 40 2001 10507 10513
56. A. Penmatsa X-ray structure of dopamine transporter elucidates antidepressant mechanism Nature 503 2013 85 90
57. 2 with the XIP region of the cardiac Na/Ca exchanger Am. J. Physiol. Cell Physiol. 278 2000 C661 C666
58. F. Buchmayer Amphetamine actions at the serotonin transporter rely on the availability of phosphatidylinositol-4,5-bisphosphate Proc. Natl. Acad. Sci. U.S.A. 110 2013 11642 11647
59. P.J. Hamilton PIP2 regulates psychostimulant behaviors through its interaction with a membrane protein Nat. Chem. Biol. 10 2014 582 589
60. M.L. Cremona Flotillin-1 is essential for PKC-triggered endocytosis and membrane microdomain localization of DAT Nat. Neurosci. 14 2011 469 477
61. A.B. Pizzo The membrane raft protein Flotillin-1 is essential in dopamine neurons for amphetamine-induced behavior in Drosophila Mol. Psychiatry 18 2013 824 833
62. A.B. Pizzo Amphetamine-induced behavior requires CaMKII-dependent dopamine transporter phosphorylation Mol. Psychiatry 19 2014 279 281
63. D. Sakrikar Attention deficit/hyperactivity disorder-derived coding variation in the dopamine transporter disrupts microdomain targeting and trafficking regulation J. Neurosci. 32 2012 5385 5397
64. R.A. Vaughan, and J.D. Foster Mechanisms of dopamine transporter regulation in normal and disease states Trends Pharmacol. Sci. 34 2013 489 496
65. 2+ regulates amphetamine-induced dopamine efflux and currents mediated by the human dopamine transporter Mol. Pharmacol. 66 2004 137 143
66. J.U. Fog Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport Neuron 51 2006 417 429
67. 2+/calmodulin-dependent protein kinase IIalpha (alphaCaMKII) controls the activity of the dopamine transporter: implications for Angelman syndrome J. Biol. Chem. 287 2012 29627 29635
68. M. Rickhag Membrane-permeable C-terminal dopamine transporter peptides attenuate amphetamine-evoked dopamine release J. Biol. Chem. 288 2013 27534 27544
69. T. Steinkellner In vivo amphetamine action is contingent on alphaCaMKII Neuropsychopharmacology 39 2014 2681 2693
70. H. Just Identification of an additional interaction domain in transmembrane domains 11 and 12 that supports oligomer formation in the human serotonin transporter J. Biol. Chem. 279 2004 6650 6657
71. C. Fenollar-Ferrer Structure and regulatory interactions of the cytoplasmic terminal domains of serotonin transporter Biochemistry 53 2014 5444 5460
72. J.D. Foster, and R.A. Vaughan Palmitoylation controls dopamine transporter kinetics, degradation, and protein kinase C-dependent regulation J. Biol. Chem. 286 2011 5175 5186
73. B.H. Falkenburger Dendrodendritic inhibition through reversal of dopamine transport Science 293 2001 2465 2470
74. M.S. Mazei-Robison Anomalous dopamine release associated with a human dopamine transporter coding variant J. Neurosci. 28 2008 7040 7046
75. D. Sulzer How addictive drugs disrupt presynaptic dopamine neurotransmission Neuron 69 2011 628 649
76. M.H. Baumann Evidence for a role of transporter-mediated currents in the depletion of brain serotonin induced by serotonin transporter substrates Neuropsychopharmacology 39 2014 1355 1365
77. J.R. Bunzow Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor Mol. Pharmacol. 60 2001 1181 1188
78. Z. Xie, and G.M. Miller Trace amine-associated receptor 1 is a modulator of the dopamine transporter J. Pharmacol. Exp. Ther. 321 2007 128 136
79. F.G. Revel Brain-specific overexpression of trace amine-associated receptor 1 alters monoaminergic neurotransmission and decreases sensitivity to amphetamine Neuropsychopharmacology 37 2012 2580 2592
80. T.D. Wolinsky The Trace Amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia Genes Brain Behav. 6 2007 628 639
81. M.H. Baumann Psychoactive 'bath salts': not so soothing Eur. J. Pharmacol. 698 2013 1 5
82. P.I. Dargan The pharmacology and toxicology of the synthetic cathinone mephedrone (4-methylmethcathinone) Drug Test. Anal. 3 2011 454 463
83. R.B. Rothman, and M.H. Baumann Therapeutic and adverse actions of serotonin transporter substrates Pharmacol. Ther. 95 2002 73 88
84. M.H. Baumann Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products Neuropsychopharmacology 38 2013 552 562
85. A.M. Leffler The analytical investigation of synthetic street drugs containing cathinone analogs Forensic Sci. Int. 234 2014 50 56
86. T. Hofmaier Aminorex, a metabolite of the cocaine adulterant levamisole, exerts amphetamine like actions at monoamine transporters Neurochem. Int. 73 2014 32 41
87. R. Rosenauer A combined approach using transporter-flux assays and mass spectrometry to examine psychostimulant street drugs of unknown content ACS Chem. Neurosci. 4 2013 182 190
88. H. Farhan Concentrative export from the endoplasmic reticulum of the gamma-aminobutyric acid transporter 1 requires binding to SEC24D J. Biol. Chem. 282 2007 7679 7689
89. K.L. Holton Nonclassical, distinct endocytic signals dictate constitutive and PKC-regulated neurotransmitter transporter internalization Nat. Neurosci. 8 2005 881 888
90. S. Sucic Switching the clientele: a lysine residing in the C terminus of the serotonin transporter specifies its preference for the coat protein complex II component SEC24C J. Biol. Chem. 288 2013 5330 5341
91. L. Sorensen Characterization of intracellular regions in the human serotonin transporter for phosphorylation sites ACS Chem. Biol. 9 2014 935 944
92. T. Sorkina RNA interference screen reveals an essential role of Nedd4-2 in dopamine transporter ubiquitination and endocytosis J. Neurosci. 26 2006 8195 8205
93. M.A. Cervinski Psychoactive substrates stimulate dopamine transporter phosphorylation and down-regulation by cocaine-sensitive and protein kinase C-dependent mechanisms J. Biol. Chem. 280 2005 40442 40449
94. J. Eriksen Visualization of dopamine transporter trafficking in live neurons by use of fluorescent cocaine analogs J. Neurosci. 29 2009 6794 6808
95. E. Sinita, and D. Coghill The use of stimulant medications for non-core aspects of ADHD and in other disorders Neuropharmacology 87C 2014 161 172
96. D.J. Heal Amphetamine, past and present - a pharmacological and clinical perspective J. Psychopharmacol. 27 2013 479 496
97. H. Greely Towards responsible use of cognitive-enhancing drugs by the healthy Nature 456 2008 702 705
98. E. Guttmann, and W. Sargant Observations on benzedrine Br. Med. J. 1 1937 1013 1015
99. S. Wood Psychostimulants and cognition: a continuum of behavioral and cognitive activation Pharmacol. Rev. 66 2014 193 221
100. M.E. Ballard Amphetamine increases errors during episodic memory retrieval J. Clin. Psychopharmacol. 34 2014 85 92